Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial

Introduction: This paper aims to evaluate the toxicity profile of additive gemcitabine to adjuvant taxane-based chemotherapy in breast cancer patients. Methods: Patients enrolled in this open-label randomized controlled Phase III study were treated with 3 cycles of epirubicin-fluorouracil-cyclophosp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Geburtshilfe Frauenheilkd
Main Authors: Schröder, L., Rack, B., Sommer, H., Koch, J. G., Weissenbacher, T., Janni, W., Schneeweiss, A., Rezai, M., Lorenz, R., Jäger, B., Schramm, A., Häberle, L., Fasching, P. A., Friedl, T. W. P., Beckmann, M. W., Scholz, C.
Formato: Artigo
Idioma:Inglês
Publicado em: Georg Thieme Verlag KG 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4873296/
https://ncbi.nlm.nih.gov/pubmed/27239063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0042-106209
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados